CureVac ist ein biopharmazeutisches Unternehmen auf dem Gebiet der mRNA-Technologie. Ziel ist die Behandlung von Krankheiten bzw. Herstellung von Impfstoffen. Das Unternehmen aus Tübingen ist im August 2020 in den USA an die Börse gegangen.
COMPANY
INVESTOR TERMSHEET
5CV
CureVac
#BGFL Mood:
-
·
#BGFL-Indicator:
-
·
Review date:
-
LEI:
529900UEP106YJJ1QR22
SECTOR:
Gesundheit
SUB-SECTOR:
Biotechnologie
CureVac
A2P71U
NL0015436031
5CV
Xetra
The basic chart view shows the price movement of CureVac. If you are interested in additional analysis switch to the advanced chart view.
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Even hardened fundamentalists probably look at the chart of a share before they start analysing it in any other way. Accordingly, boersengefluester.de (BGFL) has also developed a wide range of apps relating to chart technology and sophisticated scorings with technical chart components.
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL